News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

ICR researchers receiving a Queen's Anniversary Prize at Buckingham Palace.
Her Majesty The Queen presents cancer researchers with prize at Buckingham Palace

22/02/24

Earlier today, researchers from The Institute of Cancer Research, London, received a prestigious Queen’s Anniversary Prize on behalf of the institute, in recognition of its transformational breast cancer research programme.
Glioblastoma cells under a microscope
'Olive oil' drug shows early promise for some brain cancer patients

21/02/24

A unique drug derived from oleic acid – which naturally occurs in animal and vegetable fats such as olive oil – has shown promise for patients with an advanced form of the most common type of brain cancer, following a study led by The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London.
Cellular flow model
Researchers develop new approaches to live-track the production of different types of blood cells in mice

19/02/24

Scientists have found a way to monitor in real time how bone marrow stem cells produce the different types of cells in the blood – a process called haematopoiesis.
Graphical abstract from Choudhary paper
New study opens the door to learning more about an important driver of breast cancer

13/02/24

Through innovative exploratory work, scientists have identified a new way to study proteins that are involved in the development of the majority of breast cancers.
Proliferating cells in a tumour organoid of triple-negative breast cancer. Image credit: Dr Rebecca Marlow / ICR
New AI collaboration could advance precision therapy in breast cancer

09/02/24

A new collaboration between academic and industry researchers could help to improve clinical decision making for cancer patients – including by potentially guiding the use of immunotherapy to breast cancer patients who could benefit from it.
ICR Logo
Scientists discover how some advanced breast cancers become resistant to hormone therapy

07/02/24

New research has identified why some advanced oestrogen receptor (ER) positive breast cancers become resistant to hormone therapy, and has identified drugs currently in development that could keep disease stable for longer for these patients.
An artist's impression of The London Cancer Hub
ICR welcomes appointment of Aviva and Socius for new life-sciences development at The London Cancer Hub

22/01/24

The Institute of Cancer Research has welcomed the appointment of a new partnership to deliver a major redevelopment project at The London Cancer Hub in Sutton.
breast cancer cell
ICR welcomes recommendation of talazoparib for advanced breast cancer

19/01/24

The Institute of Cancer Research, London, strongly welcomes the news that talazoparib (trade name Talzenna) has been recommended by NICE for the treatment of advanced breast cancer.
ICR Logo
We must not rush to implement new genetic screening programmes, experts warn

15/01/24

There is a danger that population genetic screening programmes may be introduced without the necessary scrutiny and rigour that is usually applied when screening programmes are put into effect, experts have warned.
Prostate Cancer Cells 547x411px
Scientists now able to predict response to radium-223 treatment in prostate cancer bone metastases

21/12/23

Researchers have found a way to predict which patients are likely to respond to radium-223, a standard treatment for advanced prostate cancer that has spread to the bones.
Professor Clare Isacke in the ICR lab
Professor Clare Isacke wins prestigious award for women in science

19/12/23

Professor Clare Isacke has been awarded the biennial Women in Science Achievement Award by the Metastasis Research Society (MRS).
Breast cancer organoid
New understanding of devastating type of breast cancer spread could lead to better treatments

14/12/23

A new study has increased the understanding of an increasingly common complication of advanced breast cancer.


Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.